KIN101
CAS No. 610753-87-2
KIN101 ( 3-(4-Bromophenyl)-7-[(methylsulfonyl)oxy]-4-oxo-4H-chromene )
产品货号. M26270 CAS No. 610753-87-2
KIN101, an isoflavone agonist of IRF-3 dependent signaling, induces IRF-3 nuclear translocation. KIN101 has antiviral activity against RNA viruses, HCV, and RSV.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥381 | 有现货 |
|
10MG | ¥583 | 有现货 |
|
25MG | ¥1045 | 有现货 |
|
50MG | ¥1725 | 有现货 |
|
100MG | ¥2608 | 有现货 |
|
200MG | ¥3872 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称KIN101
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述KIN101, an isoflavone agonist of IRF-3 dependent signaling, induces IRF-3 nuclear translocation. KIN101 has antiviral activity against RNA viruses, HCV, and RSV.
-
产品描述KIN101, an isoflavone agonist of IRF-3 dependent signaling, induces IRF-3 nuclear translocation. KIN101 has antiviral activity against RNA viruses, HCV, and RSV.(In Vitro):KIN101 results in a significant increase in the levels of ISGs as well as other proteins downstream of IRF activation such as RIG-I and MDA5.KIN101 (10 μM; 24 hours) causes a significant decrease in the NP protein abundance. KIN 101 (10 μM; 18 hours) shows a >1 log decrease in HCV RNA levels. KIN 101 (5, 10, 20, 50 μM; 4 hours) causes a dose-dependent decrease in influenza virus infection in MRC5 cells. KIN101 (0.01, 0.1, 1, 10, 100 μM) has a significant and dose-dependent effect on the formation of foci and has an IC50 of 0.2 μM.
-
同义词3-(4-Bromophenyl)-7-[(methylsulfonyl)oxy]-4-oxo-4H-chromene
-
通路Microbiology/Virology
-
靶点HCV
-
受体NMDA
-
研究领域——
-
适应症——
化学信息
-
CAS Number610753-87-2
-
分子量395.2
-
分子式C16H11BrO5S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCS(=O)(=O)Oc1ccc2c(c1)occ(-c1ccc(Br)cc1)c2=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Parsons CG, et al. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization. Journal of Pharmacology and Experimental Therapeutics (1997), 283(3), 1264-1275
产品手册
关联产品
-
VCH-916
VCH-916 is a new nonnucleoside inhibitor of HCV NS5B polymerase.
-
Samatasvir
Samatasvir is a pan-genotypic inhibitor of the HCV non-structural protein 5A.
-
Coblopasvir
Coblopasvir (KW136, KW-136) is a novel HCV NS5A inhibitor under development for treatment of HCV infection.